导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 31.48% | 126/1050 |
| 近一周 | -2.79% | 730/1104 |
| 近一月 | -6.73% | 786/1102 |
| 近一季 | -24.70% | 1042/1092 |
| 近半年 | 18.80% | 156/1070 |
| 近一年 | 76.67% | 18/1018 |
| 近两年 | 218.78% | 42/926 |
| 近三年 | 169.99% | 44/834 |
| 成立以来 | 169.94% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.54% 78/1070 |
84.53% 86/1101 |
- - |
- - |
| 2025 | 92.30% 19/1065 |
6.02% 340/1014 |
1.12% 600/1038 |
45.60% 121/1050 |
23.20% 3/1065 |
| 2024 | 3.01% 500/1011 |
-5.12% 572/960 |
1.23% 235/983 |
3.68% 915/991 |
3.43% 183/1011 |
| 2023 | -4.63% 195/952 |
5.03% 324/880 |
-3.25% 397/895 |
-9.41% 565/915 |
3.60% 33/952 |
| 2022 | -30.44% 640/867 |
-23.79% 697/773 |
-0.41% 702/806 |
-12.24% 407/845 |
4.43% 232/867 |
| 2021 | 64.84% 5/740 |
3.11% 78/580 |
21.62% 137/659 |
18.71% 21/704 |
10.73% 62/740 |
| 2020 | 24.15% 370/554 |
2.87% 96/419 |
12.86% 378/466 |
10.16% 250/517 |
-2.93% 505/554 |
| 2019 | 32.60% 275/410 |
27.63% 511/1146 |
-5.84% 766/1228 |
1.95% 279/390 |
8.23% 227/410 |
| 2018 | -27.16% 179/349 |
- - |
-7.26% 281/990 |
-2.24% 319/1000 |
-13.09% 741/1080 |
| 2017 | -15.71% 204/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 宝盈国家安全沪港深股票A VS. 东吴新产业精选股票A(580008) |